Shattuck Labs, Inc. (STTK) Reports Phase I Results for SL-325 and Pipeline Developments
Shattuck Labs, Inc. has shared the Phase I results for its DR3 blocking antibody SL-325, along with updates on its ongoing pipeline.
7 articles tagged with "biotech"
Shattuck Labs, Inc. has shared the Phase I results for its DR3 blocking antibody SL-325, along with updates on its ongoing pipeline.
A Delaware judge has dismissed a lawsuit filed by a former executive of Aurion Biotech, which challenged a stockholder's alleged takeover and the abandonment of a planned IPO.
At the recent BIO event, insights into Lilly and Chai's collaboration were shared, alongside discussions on drug manufacturing and the biotech landscape.
The recent departure of significant FDA officials has sparked worries among biotech executives about the future of rare disease drug development, emphasizing the need for regulatory stability.